MEDIROM Healthcare Technologies Inc.
MRMConsumer CyclicalNASDAQPersonal Services · Last scanned Oct 26, 2026
Scan Results
Daily timeframeHeadquartered within the consumer cyclical sector, MEDIROM Healthcare Technologies Inc. focuses on Personal Services services and products. MEDIROM Healthcare Technologies Inc., together with its subsidiaries, provides holistic health services in Japan. With a market capitalization of $2.7M, it sits in micro-cap territory. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty.
Market Cap
$2.7M
Beta
1.26
P/E (TTM)
0.87
P/E (Fwd)
—
EPS (TTM)
$0.40
EPS (Fwd)
—
ROE
53.2%
ROA
-1.8%
Cash
$32.7M
Total Debt
$3.92B
Free CF
$312.5M
52W Change
-87.0%
Annual Financials
Cash vs Debt
Where MRM stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, MRM finished 63.64% below its 150-day moving average ($0.99) and 67.86% below its 200-day moving average ($1.12). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is MRM overbought or oversold?
At the October 20, 2026 close, MRM's RSI(14) was 13.7, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $32.7M in cash, though total debt stands at $3.92B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $312.5M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 53.2%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $5.41B (2021) to $8.30B (2024), reflecting a 53% increase over the period.
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing MRM.